Vital Technologies

Microencapsulated Wellness Products

Health Tech & Life Sciences
non_active
Mature Founded 2013
LinkedIn
Last updated 2026-06-18
Total raised
$8.0M
Last: seed 2019-09
Stage
Mature
Founded
2013
Headcount
5
HQ
Sector
Health Tech & Life Sciences

About

Vital develops and produces patented microencapsulated GRAS natural actives and commercial performance-enhancing formulation products designed for seamless incorporation into commercially available food and beverage products. The company’s use of microencapsulated particles under 250 microns in size results in fast-acting recovery solutions and an exceptional consumption experience, even with ultra-dose ingredients and formulations.

Vital’s patented nutrient transfer technology (NT2) pharma-class micro-encapsulation technology platform supports any type of powerful natural active, including nootropics, adaptogens, botanicals, amino acids, electrolytes, and vitamins. The NT2 platform enhances the properties of any natural active by adding one or more of the following: complete taste isolation at high dosing levels, active protection of external stressors, triggered release profiles, and an array of sophisticated release profiles.

Funding history · 1 round · $8.0M total

2019-09
seed $8.0M

Q&A

What is Vital Technologies' primary business?
Vital Technologies develops and produces patented microencapsulated GRAS natural actives and commercial performance-enhancing formulation products for food and beverage integration.
What is the status of Vital Technologies?
Vital Technologies is currently non-active and ceased to operate in April 2026.
When was Vital Technologies founded?
Vital Technologies was founded in November 2013.
How much funding has Vital Technologies raised in total?
Vital Technologies has raised a total of $8,000,000 USD.
When was Vital Technologies' last funding round and who were the lead investors?
Vital Technologies' last funding round was a seed round in September 2019, with SIBF VC as the lead investor.
What is Vital Technologies' patented technology called?
Vital Technologies' patented technology platform is called Nutrient Transfer Technology (NT2) pharma-class micro-encapsulation technology.
What is the employee count for Vital Technologies?
Vital Technologies has 1-10 employees.
Who is the CEO of Vital Technologies?
Doron Polity is the CEO of Vital Technologies.

Team · 3

Founder · Founder & CIO (no longer with the company)
LinkedIn ↗
Head of Formulation R&D
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Agriculture & Food TechnologiesFood TechNovel Food & IngredientsHealth Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

pharmaceuticalsnutritionnovel-ingredientsfoodtechfood-and-beveragesupplements
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)